• Ashwagandha Digestion Mapped by LC–MS/MS

  2026-08-11

  This 2026 study combines simulated gastrointestinal digestion, targeted LC–MS/MS, untargeted metabolomics, and molecular networking to determine how Withania somnifera extract constituents change before absorption. Its central finding is that digestive stability depends on both compound identity and plant tissue, providing a more realistic framework for preclinical evaluation of complex botanical mixtures.

• EZ Cap EGFP mRNA 5-moUTP for Reporter Workflows

  2026-08-10

  Build more reproducible reporter, delivery, and translation studies with a Cap1-, 5-moU-modified EGFP transcript. This guide connects practical cell-based workflows and in vivo imaging with lessons from a lipid nanoparticle cancer study, while emphasizing controls, optimization, and troubleshooting.

• VX-765 Workflows for Caspase-1 and Pyroptosis

  2026-08-09

  VX-765 provides a selective way to separate caspase-1-driven cytokine maturation and pyroptosis from broader inflammatory or transcriptional stress responses. This practical guide covers biochemical assays, cell-based cytokine workflows, disease-model interpretation, and troubleshooting for studies involving IL-1β, IL-18, macrophages, and CD4 T cells.

• Acridine Orange hydrochloride: Technical Guide

  2026-08-08

  Acridine Orange hydrochloride provides differential fluorescent labeling of nucleic acids, supporting DNA and RNA staining, cell cycle analysis, apoptosis detection, and flow cytofluorometric workflows. Use freshly prepared solutions with validated instrument settings; the dye should not be used as a standalone proof of apoptosis or stored as a solution for extended periods.

• HOXC8, Caspase-1, and Pyroptosis in NSCLC

  2026-08-07

  A 2025 Cell Death and Disease study identifies HOXC8 as a transcriptional suppressor of caspase-1 expression in non-small cell lung carcinoma. Loss of HOXC8 raises caspase-1 abundance and triggers ASC-independent pyroptosis, revealing a mechanism by which tumor cells may evade inflammatory cell death and suggesting experimental strategies for interrogating this caspase signaling pathway.

• Gold(I) Phosphine Complex Triggers ROS-Mediated Apoptosis in

  2026-08-07

  This study introduces a novel gold(I) phosphine complex (Compound 5) that selectively induces apoptosis in prostate cancer cells by disrupting thioredoxin reductase and elevating intracellular reactive oxygen species. The findings provide strong evidence for targeting redox homeostasis as an antitumor strategy, with implications for the development of more effective therapeutics against treatment-resistant prostate cancer.

• Solanesol (B8776): Technical Guidance for Research Workflows

  2026-08-06

  Solanesol is a high-purity polyisoprenoid alcohol designed for precise research applications involving hydrophobic compounds, especially in apoptosis research, DNA damage and repair studies, and metabolic enzyme assays. It is unsuitable for aqueous or ethanol-based systems and should not be used for diagnostic or clinical purposes.

• HOXC8 Suppresses Pyroptosis in NSCLC via Caspase-1 Repressio

  2026-08-06

  The reference study reveals that HOXC8, a homeobox transcription factor, mitigates pyroptotic cell death in non-small cell lung carcinoma (NSCLC) by repressing caspase-1 transcription through HDAC1/2 recruitment. This mechanistic insight clarifies the link between HOXC8 expression and tumorigenesis, offering new directions for inflammation and apoptosis research.

• Cy5.5 NHS Ester: Advanced Near-Infrared Labeling for In Vivo

  2026-08-05

  Cy5.5 NHS ester (non-sulfonated) unlocks ultra-sensitive, deep-tissue fluorescence labeling for protein, peptide, and nanoparticle conjugation—empowering next-generation optical imaging and translational research. This guide details actionable workflows, troubleshooting strategies, and new insights from recent non-invasive neuromodulation applications.

• Z-VAD-FMK for Apoptosis Inhibition: Protocols and Pitfalls

  2026-08-05

  Z-VAD-FMK is the definitive tool for dissecting caspase-dependent apoptosis, offering reliable, cell-permeable, and irreversible inhibition in diverse experimental systems. This article translates cutting-edge reference findings into actionable workflows and troubleshooting strategies for apoptosis research, with stepwise guidance and comparative insights.

• JEV Disrupts Lysosomal Function via LAMP1/2 Downregulation

  2026-08-04

  This study reveals how Japanese Encephalitis Virus (JEV) infection impairs lysosomal function by downregulating LAMP1 and LAMP2, primarily via the autophagy-lysosome axis mediated by the viral NS4B protein. These findings provide novel mechanistic insight into JEV-host interactions and suggest new approaches for exploring viral pathogenesis and cell death pathways.

• Tigecycline in Translational Research: Surmounting MDR Barri

  2026-08-04

  Explore how Tigecycline, a next-generation glycylcycline antibiotic, offers strategic solutions to the escalating threat of multidrug-resistant pathogens in translational research. This thought-leadership article bridges mechanistic insight with actionable guidance, highlights emerging resistance dynamics, and charts a roadmap for innovative experimental design and clinical impact.

• (R)-MG132: The Gold Standard Negative Control for Proteasome

  2026-08-03

  (R)-MG132 offers rigorous, stereochemically precise negative controls for proteasome inhibition studies, eliminating ambiguity in mechanistic research. Its functionally inactive profile enables researchers to pinpoint true proteasome-dependent effects and build robust experimental workflows.

• p-Cresyl Sulfate Drives Valvular Calcification via Klotho/SI

  2026-08-03

  This study demonstrates that p-cresyl sulfate, a protein-bound uremic toxin, directly accelerates calcification of aortic valvular interstitial cells by disrupting klotho and sirtuin-1 signaling. These findings clarify a mechanistic link between uremic toxin accumulation and heightened cardiovascular risk in chronic kidney disease, informing future strategies for biomarker-driven research and targeted intervention.

• CH 223191: Benchmark Aryl Hydrocarbon Receptor Antagonist

  2026-08-02

  CH 223191 is a potent, nanomolar aryl hydrocarbon receptor antagonist that enables precise dissection of AhR signaling and dioxin toxicity mechanisms. It reliably inhibits cytochrome P450 1A1 induction and mitigates toxic effects in vitro and in vivo, making it a gold-standard tool for environmental toxicology research.

15855 records 2/1057 page Previous Next 12345 下5页 Last page